High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study

Anoop S V Shah, Atul Anand, Yader Sandoval, Kuan Ken Lee, Stephen W Smith, Philip D Adamson, Andrew R Chapman, Timothy Langdon, Dennis Sandeman, Amar Vaswani, Fiona E Strachan, Amy Ferry, Alexandra G Stirzaker, Alan Reid, Alasdair J Gray, Paul O Collinson, David A McAllister, Fred S Apple, David E Newby, Nicholas L Mills, High-STEACS investigators, Nicholas L Mills, Fiona E Strachan, Anoop S V Shah, Atul Anand, Amy V Ferry, Andrew Chapman, Phil Adamson, Nicholas L Mills, David E Newby, Keith A A Fox, Colin Berry, Simon Walker, Christopher J Weir, Ian Ford, Nicholas L Mills, David Newby, Alasdair Gray, Keith A A Fox, Colin Berry, Simon Walker, Paul O Collinson, Fred S Apple, Alan Reid, Anne Cruikshank, Iain Findlay, Shannon Amoils, John Norrie, Christopher Weir, Colin Fischbacher, Bernard Croal, Stephen J Leslie, Anoop S V Shah, Atul Anand, Yader Sandoval, Kuan Ken Lee, Stephen W Smith, Philip D Adamson, Andrew R Chapman, Timothy Langdon, Dennis Sandeman, Amar Vaswani, Fiona E Strachan, Amy Ferry, Alexandra G Stirzaker, Alan Reid, Alasdair J Gray, Paul O Collinson, David A McAllister, Fred S Apple, David E Newby, Nicholas L Mills, High-STEACS investigators, Nicholas L Mills, Fiona E Strachan, Anoop S V Shah, Atul Anand, Amy V Ferry, Andrew Chapman, Phil Adamson, Nicholas L Mills, David E Newby, Keith A A Fox, Colin Berry, Simon Walker, Christopher J Weir, Ian Ford, Nicholas L Mills, David Newby, Alasdair Gray, Keith A A Fox, Colin Berry, Simon Walker, Paul O Collinson, Fred S Apple, Alan Reid, Anne Cruikshank, Iain Findlay, Shannon Amoils, John Norrie, Christopher Weir, Colin Fischbacher, Bernard Croal, Stephen J Leslie

Abstract

Background: Suspected acute coronary syndrome is the commonest reason for emergency admission to hospital and is a large burden on health-care resources. Strategies to identify low-risk patients suitable for immediate discharge would have major benefits.

Methods: We did a prospective cohort study of 6304 consecutively enrolled patients with suspected acute coronary syndrome presenting to four secondary and tertiary care hospitals in Scotland. We measured plasma troponin concentrations at presentation using a high-sensitivity cardiac troponin I assay. In derivation and validation cohorts, we evaluated the negative predictive value of a range of troponin concentrations for the primary outcome of index myocardial infarction, or subsequent myocardial infarction or cardiac death at 30 days. This trial is registered with ClinicalTrials.gov (number NCT01852123).

Findings: 782 (16%) of 4870 patients in the derivation cohort had index myocardial infarction, with a further 32 (1%) re-presenting with myocardial infarction and 75 (2%) cardiac deaths at 30 days. In patients without myocardial infarction at presentation, troponin concentrations were less than 5 ng/L in 2311 (61%) of 3799 patients, with a negative predictive value of 99·6% (95% CI 99·3-99·8) for the primary outcome. The negative predictive value was consistent across groups stratified by age, sex, risk factors, and previous cardiovascular disease. In two independent validation cohorts, troponin concentrations were less than 5 ng/L in 594 (56%) of 1061 patients, with an overall negative predictive value of 99·4% (98·8-99·9). At 1 year, these patients had a lower risk of myocardial infarction and cardiac death than did those with a troponin concentration of 5 ng/L or more (0·6% vs 3·3%; adjusted hazard ratio 0·41, 95% CI 0·21-0·80; p<0·0001).

Interpretation: Low plasma troponin concentrations identify two-thirds of patients at very low risk of cardiac events who could be discharged from hospital. Implementation of this approach could substantially reduce hospital admissions and have major benefits for both patients and health-care providers.

Funding: British Heart Foundation and Chief Scientist Office (Scotland).

Copyright © 2015 Shah et al. Open Access article distributed under the terms of CC BY-NC-ND. Published by Elsevier Ltd.. All rights reserved.

Figures

Figure 1
Figure 1
Cardiac troponin I concentration at presentation and risk of myocardial infarction (A) Negative predictive value of a range of troponin I concentrations at presentation for the composite outcome of index myocardial infarction, and myocardial infarction or cardiac death at 30 days. (B) Cumulative proportion of patients with suspected acute coronary syndrome with troponin concentrations below each threshold.
Figure 2
Figure 2
Negative predictive value of troponin concentrations

Figure 3

Cumulative incidence of myocardial infarction…

Figure 3

Cumulative incidence of myocardial infarction or cardiac death in patients with troponin concentrations…

Figure 3
Cumulative incidence of myocardial infarction or cardiac death in patients with troponin concentrations less than the 99th centile Patients without index myocardial infarction were stratified into two groups based on the troponin concentration at presentation. Compared to patients with troponin concentrations ≥5 ng/L, patients with troponin concentrations vs 3·3%; hazard ratio 0·41, 95% CI 0·21–0·80; log-rank p<0·0001).
Figure 3
Figure 3
Cumulative incidence of myocardial infarction or cardiac death in patients with troponin concentrations less than the 99th centile Patients without index myocardial infarction were stratified into two groups based on the troponin concentration at presentation. Compared to patients with troponin concentrations ≥5 ng/L, patients with troponin concentrations vs 3·3%; hazard ratio 0·41, 95% CI 0·21–0·80; log-rank p<0·0001).

References

    1. Makam AN, Nguyen OK. Use of cardiac biomarker testing in the emergency department. JAMA Intern Med. 2015;175:67–75.
    1. Goodacre S, Cross E, Arnold J, Angelini K, Capewell S, Nicholl J. The health care burden of acute chest pain. Heart. 2005;91:229–230.
    1. Zhelev Z, Hyde C, Youngman E. Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis. BMJ. 2015;350:h15.
    1. Skinner JS, Smeeth L, Kendall JM, Adams PC, Timmis A. NICE guidance. Chest pain of recent onset: assessment and diagnosis of recent onset chest pain or discomfort of suspected cardiac origin. Heart. 2010;96:974–978.
    1. Goodacre S, Thokala P, Carroll C. Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome. Health Technol Assess. 2013;17:1–188.
    1. Niska R, Bhuiya F, Xu J. National Hospital Ambulatory Medical Care Survey: 2007 emergency department summary. Natl Health Stat Report. 2010;26:1–31.
    1. Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem. 2012;58:54–61.
    1. Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin Chem. 2012;58:1574–1581.
    1. NICE . Myocardial infarction (acute): early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 assays): DC15. National Institute for Health and Care Excellence; London: 2014.
    1. Thygesen K, Alpert JS, Jaffe AS. Third universal definition of myocardial infarction. Circulation. 2012;126:2020–2035.
    1. Mills NL, Churchhouse AM, Lee KK. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA. 2011;305:1210–1216.
    1. Shah AS, Griffiths M, Lee KK. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ. 2015;350:g7873.
    1. Body R, Carley S, McDowell G. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J Am Coll Cardiol. 2011;58:1332–1339.
    1. Rubini Gimenez M, Hoeller R, Reichlin T. Rapid rule out of acute myocardial infarction using undetectable levels of high-sensitivity cardiac troponin. Int J Cardiol. 2013;168:3896–3901.
    1. Bandstein N, Ljung R, Johansson M, Holzmann MJ. Undetectable high-sensitivity cardiac troponin T level in the emergency department and risk of myocardial infarction. J Am Coll Cardiol. 2014;63:2569–2578.
    1. Mills NL, Lee KK, McAllister DA. Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study. BMJ. 2012;344:e1533.
    1. Granger CB, Goldberg RJ, Dabbous O. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163:2345–2353.
    1. Shah AS, Newby DE, Mills NL. High sensitivity cardiac troponin in patients with chest pain. BMJ. 2013;347:f4222.
    1. Chin CW, Shah AS, McAllister DA. High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. Eur Heart J. 2014;35:2312–2321.
    1. Shah AS, Chin CW, Vassiliou V. Left ventricular hypertrophy with strain and aortic stenosis. Circulation. 2014;130:1607–1616.
    1. Shah AS, McAllister DA, Mills R. Sensitive troponin assay and the classification of myocardial infarction. Am J Med. 2015;128:493–501.
    1. Brown LD, Cai TT, DasGupta A. Interval estimation for a binomial proportion. Stat Sci. 2001;16:101–133.
    1. Body R, Burrows G, Carley S. High-sensitivity cardiac troponin t concentrations below the limit of detection to exclude acute myocardial infarction: a prospective evaluation. Clin Chem. 2015;61:983–989.
    1. Than M, Cullen L, Aldous S. 2-hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J Am Coll Cardiol. 2012;59:2091–2098.
    1. Carlton EW, Cullen L, Than M, Gamble J, Khattab A, Greaves K. A novel diagnostic protocol to identify patients suitable for discharge after a single high-sensitivity troponin. Heart. 2015;101:1041–1046.
    1. Cullen L, Mueller C, Parsonage WA. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol. 2011;62:1242–1249.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel